December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Chul Kim: Neoadjuvant and perioperative chemoimmunotherapy in resectable NSCLC
Oct 20, 2024, 14:46

Chul Kim: Neoadjuvant and perioperative chemoimmunotherapy in resectable NSCLC

Chul Kim shared on X:

“Neoadjuvant and periop chemoimmunotherapy regimens have improved outcomes in resectable NSCLC. This setting offers an excellent platform for testing novel agents and biomarkers. Many studies led by the speaker, Dr. Tina Cascone.

Chul Kim

More posts featuring Chul Kim on oncodaily.com

Dr. Chul Kim holds the position of Associate Professor at Georgetown University, specializing in thoracic oncology. Dr. Kim was recognized with the Norman Rales Young Investigator Award by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) in 2018.

In 2021, he was presented with the John F. Potter, MD, Award by Georgetown Lombardi Comprehensive Cancer Center. Dr. Kim actively contributes to the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has authored more than 60 articles in reputable peer-reviewed journals.